It is tissue-specific, and in both in vitro and in vivo preclinical models, has been shown to positively affect lipid profiles and skeletal-related markers via antiresorptive affects, and displays estrogen receptor interaction without stimulating the endometrium, causing breast cancer cell proliferation, or negatively affecting the central nervous system. Here, ESR1 is linked to breast carcinoma.